These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39575718)

  • 1. Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno-Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction.
    Shi Y; Perez-Bonilla P; Chen X; Tam K; Marshall M; Morin J; LaViolette B; Kue NR; Damilano F; Miller RA; Zhang BB; Roth Flach RJ; Hirenallur-Shanthappa D
    J Am Heart Assoc; 2024 Dec; 13(23):e035894. PubMed ID: 39575718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction.
    Moraña-Fernández S; Vázquez-Abuín X; Aragón-Herrera A; Anido-Varela L; García-Seara J; Otero-García Ó; Rodríguez-Penas D; Campos-Toimil M; Otero-Santiago M; Rodrigues A; Gonçalves A; Pereira Morais J; Alves IN; Sousa-Mendes C; Falcão-Pires I; González-Juanatey JR; Feijóo-Bandín S; Lago F
    Biochem Pharmacol; 2024 Dec; 230(Pt 1):116571. PubMed ID: 39424202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials.
    Lu H; Claggett BL; Packer M; Lam CSP; Swedberg K; Rouleau J; Zile MR; Lefkowitz M; Desai AS; Jhund P; McMurray JJV; Solomon SD; Vaduganathan M
    JAMA Cardiol; 2024 Nov; 9(11):1047-1052. PubMed ID: 39210725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study.
    Palazzuoli A; Pirrotta F; Cartocci A; Delcuratolo E; Dini FL; Correale M; Dattilo G; Masarone D; Scelsi L; Ghio S; Tocchetti CG; Mercurio V; Brunetti ND; Nodari S; Barillà F; Ambrosio G; Carluccio E
    Ther Adv Cardiovasc Dis; 2024; 18():17539447241285136. PubMed ID: 39611607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.
    Shaddy R; Burch M; Kantor PF; Solar-Yohay S; Garito T; Zhang S; Kocun M; Mao C; Cilliers A; Wang X; Canter C; Rossano J; Wallis G; Menteer J; Daou L; Kusa J; Tokel K; Dilber D; Xu Z; Xiao T; Halnon N; Daly KP; Bock MJ; Zuckerman W; Singh TP; Chakrabarti M; Levitas A; Senni M; Grutter G; Kim GB; Song J; Lee HD; Chen CK; Sanchez-de-Toledo J; Law Y; Wanitkun S; Cui Y; Anjos R; Mese T; Bonnet D;
    Circulation; 2024 Nov; 150(22):1756-1766. PubMed ID: 39319469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction.
    Stegmann T; Parentin L; Schirmer SH; Lavall P; Hagendorff A; Laufs U; Lavall D
    Am J Physiol Heart Circ Physiol; 2024 Dec; 327(6):H1477-H1489. PubMed ID: 39453422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICLE EJECTION FRACTION (HFPEF) AND RIGHT VENTRICLE INVOLVEMENT IN PATIENTS WITH NORMAL SINUS RHYTHM AND ATRIAL FIBRILLATION; A SMALL OBSERVATIONAL STUDY: RELEVANCE OF THE PROBLEM, DIAGNOSTIC APPROACH, ECHOCARDIOGRAPHIC EVALUATION OF RIGHT VENTRICLE.
    Kobalava S; Tsverava M; Tsetskhladze E
    Georgian Med News; 2024 Sep; (354):66-74. PubMed ID: 39580830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection?
    Castillo RL; Farías J; Sandoval C; González-Candia A; Figueroa E; Quezada M; Cruz G; Llanos P; Jorquera G; Kostin S; Carrasco R
    Antioxidants (Basel); 2024 Nov; 13(11):. PubMed ID: 39594530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow?
    Masarone D; Valente F; Verrengia M; Contaldi C; di Palma V; Falco L; Catapano D; di Lorenzo E
    J Clin Med; 2024 Nov; 13(22):. PubMed ID: 39598011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 9 Inhibition Combined With Valsartan and With Sacubitril/Valsartan in Experimental Ovine Heart Failure.
    Scott NJA; Charles CJ; Prickett TCR; Frampton CM; Richards AM; Rademaker MT
    J Am Heart Assoc; 2024 Dec; 13(23):e036689. PubMed ID: 39575752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of optimisation to contemporary HFrEF medical therapy with sacubitril/valsartan (Entresto) and dapaglifloziN on left Ventricular reverse remodelling as demonstrated by cardiac magnetic resonance (CMR) Imaging: the ENVI study.
    Zheng A; Adam R; Peebles C; Harden S; Shambrook J; Abbas A; Vedwan K; Adam G; Haydock P; Cowburn P; Young C; Long J; Walkden M; Smith S; Greenwood E; Olden P; Flett A
    Open Heart; 2024 Dec; 11(2):. PubMed ID: 39622578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel ovine model of hypertensive heart failure with preserved ejection fraction.
    Chang JW; Chen S; Hamilton C; Shanks J; Pachen M; Pauza A; George B; Ramchandra R
    Am J Physiol Heart Circ Physiol; 2024 Dec; 327(6):H1490-H1502. PubMed ID: 39546298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pathological mechanisms in a mouse model of heart failure with preserved ejection fraction.
    Rosas PC; Neves LAA; Patel N; Tran D; Pereira CH; Bonilla KR; Zheng J; Sun J; Alvarado FJ; Banach K
    Am J Physiol Heart Circ Physiol; 2024 Dec; 327(6):H1524-H1543. PubMed ID: 39485297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.
    Sobhy M; Eletriby A; Ragy H; Kandil H; Saleh MA; Farag N; Guindy R; Bendary A; Nayel AME; Shawky A; Khairy A; Mortada A; Zarif B; Badran H; Khorshid H; Mahmoud K; Said K; Leon K; Abdelsabour M; Tawfik M; Abdelmegid MAF; Koriem M; Loutfi M; Wadie M; Elnoamany M; Sadaka M; Seleem M; Zahran M; Amin OA; Elkaffas S; Ayad S; Kilany WE; Ammar W; Elawady W; Elhammady W; Abdelhady Y
    Cardiol Ther; 2024 Dec; 13(4):707-736. PubMed ID: 39455534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice.
    Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N
    Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.